Biotech · Public company · Boston, MA, US
Ironwood Pharmaceuticals Inc
Ticker IRWD · SEC CIK 0001446847
Track this companyFree. Adds Ironwood Pharmaceuticals Inc to your Dealase workspace and tells you when its record changes.
Clinical trials231 recruiting or active
Pipeline programs20From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline20
- IW-3718Phase 3 · Gastroesophageal Reflux Disease (GERD)ClinicalTrials.gov · fetched Nov 12, 2026
- LinaclotidePhase 3 · Irritable Bowel Syndrome Characterized by ConstipationClinicalTrials.gov · fetched Nov 12, 2026
- Standard-dose PPIs QDPhase 3 · Gastroesophageal Reflux Disease (GERD)ClinicalTrials.gov · fetched Nov 12, 2026
- IW-3300 rectal foamPhase 2 · Interstitial CystitisClinicalTrials.gov · fetched Nov 12, 2026
- IW-3718Phase 2 · Gastroesophageal Reflux DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- IW-6118Phase 2 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- LinaclotidePhase 2 · Irritable Bowel Syndrome With ConstipationClinicalTrials.gov · fetched Nov 12, 2026
- MD-7246Phase 2 · Irritable Bowel Syndrome With Diarrhea (IBS-D)ClinicalTrials.gov · fetched Nov 12, 2026
- Naproxen SodiumPhase 2 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- PPIPhase 2 · Gastroesophageal Reflux DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- DigoxinPhase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- GlyburidePhase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- IW-3300Phase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- IW-3718Phase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- LevothyroxinePhase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- Microgestin®Phase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- colchicineGoutClinicalTrials.gov · fetched Nov 12, 2026
- corticosteroidsGoutClinicalTrials.gov · fetched Nov 12, 2026
- LesinuradGoutClinicalTrials.gov · fetched Nov 12, 2026
- XOIGoutClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials23
- A Study of Virtual Reality and Linaclotide for IBS-CNA · RECRUITING · started May 31, 2024ClinicalTrials.gov NCT05796388 · fetched Nov 12, 2026
- A Study to Assess Adverse Events and Change in Disease Activity in Pediatric Participants (Age 6 Months to <2 Years) With Functional Constipation Who Are Treated With LinaclotidePHASE2 · COMPLETED · started Apr 27, 2023ClinicalTrials.gov NCT05760313 · fetched Nov 12, 2026
- A Phase 2 Study of IW-3300 for the Treatment of Bladder Pain in Subjects With Interstitial Cystitis/Bladder Pain SyndromePHASE2 · TERMINATED · started Mar 28, 2023ClinicalTrials.gov NCT05740007 · fetched Nov 12, 2026
- A Study to Assess Adverse Events and Change in Symptoms With Linaclotide Versus Placebo in Pediatric Subjects, Ages 2 to 5 Years, With Functional ConstipationPHASE3 · COMPLETED · started Dec 29, 2022ClinicalTrials.gov NCT05652205 · fetched Nov 12, 2026
- A Study of Multiple-ascending Doses of IW-3300 in Healthy SubjectsPHASE1 · COMPLETED · started May 17, 2022ClinicalTrials.gov NCT05362695 · fetched Nov 12, 2026
- A Study of Single Ascending Doses of IW-3300 in Healthy VolunteersPHASE1 · COMPLETED · started Jan 18, 2022ClinicalTrials.gov NCT05188261 · fetched Nov 12, 2026
- Long-term Safety of Linaclotide in Pediatric Participants With FC or IBS-CPHASE3 · COMPLETED · started Nov 19, 2019ClinicalTrials.gov NCT04166058 · fetched Nov 12, 2026
- Linaclotide Safety and Efficacy in 2 to 5-Year-Old Participants With Functional ConstipationPHASE2 · COMPLETED · started Oct 14, 2019ClinicalTrials.gov NCT04110145 · fetched Nov 12, 2026
- Linaclotide Safety and Efficacy in Pediatric Participants, 6 to 17 Years of Age, With Irritable Bowel Syndrome With Constipation (IBS-C) or Functional Constipation (FC)PHASE3 · COMPLETED · started Oct 1, 2019ClinicalTrials.gov NCT04026113 · fetched Nov 12, 2026
- A Study of MD-7246 to Treat Abdominal Pain in Patients With Diarrhea-predominant Irritable Bowel SyndromePHASE2 · COMPLETED · started May 1, 2019ClinicalTrials.gov NCT03931785 · fetched Nov 12, 2026
- Study to Evaluate the Effect of IW-3718 on the Pharmacokinetics of Oral Contraceptive, Levothyroxine, Glyburide, and Digoxin in Healthy Adult VolunteersPHASE1 · COMPLETED · started Mar 11, 2019ClinicalTrials.gov NCT03856970 · fetched Nov 12, 2026
- Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors (PPIs)PHASE3 · COMPLETED · started Sep 6, 2018ClinicalTrials.gov NCT03561883 · fetched Nov 12, 2026
- A Trial of IW-3718 for 8 Weeks in Patients With Persistent Gastroesophageal Reflux Disease (GERD) Receiving Proton Pump Inhibitors (PPIs)PHASE3 · TERMINATED · started Jun 20, 2018ClinicalTrials.gov NCT03561090 · fetched Nov 12, 2026
- A Trial of Linaclotide 290 μg in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)PHASE3 · COMPLETED · started Jun 20, 2018ClinicalTrials.gov NCT03573908 · fetched Nov 12, 2026
- A Phase 4 Safety and Efficacy Study to Evaluate Lesinurad 200 mg in Participants With Gout and Renal ImpairmentPHASE4 · TERMINATED · started Jul 19, 2017ClinicalTrials.gov NCT03226899 · fetched Nov 12, 2026
- A Trial of IW-3718 for 8 Weeks in Patients With Symptomatic Gastroesophageal Reflux Disease (GERD)PHASE2 · COMPLETED · started Mar 1, 2016ClinicalTrials.gov NCT02637557 · fetched Nov 12, 2026
- A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 6-17 Years Who Fulfill Modified Rome III Criteria for Child/Adolescent Functional Constipation (FC)PHASE2 · COMPLETED · started Nov 3, 2015ClinicalTrials.gov NCT02559570 · fetched Nov 12, 2026
- An Open-Label, Long-term Study to Assess the Immunogenicity of LINZESS® (Linaclotide) Administered Orally to Adult Participants With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic ConstipationPHASE4 · COMPLETED · started Nov 1, 2015ClinicalTrials.gov NCT02590432 · fetched Nov 12, 2026
- A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With ConstipationPHASE2 · TERMINATED · started Nov 1, 2015ClinicalTrials.gov NCT02559817 · fetched Nov 12, 2026
- Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)PHASE2 · COMPLETED · started Oct 22, 2015ClinicalTrials.gov NCT02559206 · fetched Nov 12, 2026
- Phase 2 Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered to Patients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer PainPHASE2 · COMPLETED · started Oct 31, 2014ClinicalTrials.gov NCT02270983 · fetched Nov 12, 2026
- Study to Evaluate Efficacy and Safety of IW-6118 in Patients Undergoing Third Molar ExtractionPHASE2 · COMPLETED · started Jun 1, 2010ClinicalTrials.gov NCT01107236 · fetched Nov 12, 2026
- An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With ConstipationPHASE3 · COMPLETED · started Oct 31, 2008ClinicalTrials.gov NCT00765999 · fetched Nov 12, 2026
SEC filings12
- 10-Q · 10-QSEC EDGAR · filed Nov 5, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Nov 5, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Oct 16, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 6, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Aug 6, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Jun 18, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Jun 15, 2026 · fetched Nov 12, 2026
- 8-K/A · FORM 8-K/ASEC EDGAR · filed May 21, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed May 13, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed May 7, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed May 7, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Mar 11, 2026 · fetched Nov 12, 2026